is glp 1 prescription only GLP-1 Updates for Employers: Demand, Shortages, and Cost If it's not FDA-approved, it's

GLP-1 receptor agonists in the treatment of type 2 diabetesstate-of-the-art

The way we manage GLP-1 drugs within them will shape womens health and health inequality for decades

Our 2025 study in JMIR Formative Research examined 12-month outcomes for participants using semaglutide with behavioural support and found 1 : 19.1% average weight loss at 12 months for active subscribers 77.7% achieved at least 10% weight loss 61.5% achieved at least 15% weight loss 69% reported no side effects by month 12 These are completer results (people who stayed on the programme for 12 months), not intent-to-treat

BPC-157 acts at the site of injury to produce a well-perfused local environment

Our guide on how fast semaglutide works provides a timeline comparison that many readers find helpful

& Poellinger, L